Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,914 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
Han SH, Martin P, Edelstein M, Hu R, Kunder G, Holt C, Saab S, Durazo F, Goldstein L, Farmer D, Ghobrial RM, Busuttil RW. Han SH, et al. Among authors: martin p. Liver Transpl. 2003 Feb;9(2):182-7. doi: 10.1053/jlts.2003.50002. Liver Transpl. 2003. PMID: 12548512 Free article.
Aplastic anemia complicating orthotopic liver transplantation.
Goss JA, Schiller GJ, Martin P, Seu P, Stribling R, McDiarmid SV, Shackleton CR, Markowitz JS, Nuesse BJ, Goldstein LI, Busuttil RW. Goss JA, et al. Among authors: martin p. Hepatology. 1997 Oct;26(4):865-9. doi: 10.1002/hep.510260410. Hepatology. 1997. PMID: 9328306
Significance of early aminotransferase elevation after liver transplantation.
Rosen HR, Martin P, Goss J, Donovan J, Melinek J, Rudich S, Imagawa DK, Kinkhabwala M, Seu P, Busuttil RW, Shackleton CR. Rosen HR, et al. Among authors: martin p. Transplantation. 1998 Jan 15;65(1):68-72. doi: 10.1097/00007890-199801150-00013. Transplantation. 1998. PMID: 9448146
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Ghobrial RM, Colquhoun S, Rosen H, Hollis P, Ponthieux S, Pakrasi A, Farmer DG, Markman JF, Markowitz J, Drazan K, Yersiz H, Singer J, Stribling R, Arnout W, Holt CD, Goss J, Imagawa D, Seu P, Goldstein LI, Shackleton CR, Martin P, Busuttil RW. Ghobrial RM, et al. Among authors: martin p. Transplant Proc. 1998 Jun;30(4):1470-1. doi: 10.1016/s0041-1345(98)00320-0. Transplant Proc. 1998. PMID: 9636597 No abstract available.
A simple model to estimate survival after retransplantation of the liver.
Markmann JF, Gornbein J, Markowitz JS, Levy MF, Klintmalm GB, Yersiz H, Morrisey M, Drazan K, Farmer DG, Ghobrial RM, Goss J, Seu P, Martin P, Goldstein LI, Busuttil RW. Markmann JF, et al. Among authors: martin p. Transplantation. 1999 Feb 15;67(3):422-30. doi: 10.1097/00007890-199902150-00015. Transplantation. 1999. PMID: 10030290
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW. Ghobrial RM, et al. Among authors: martin p. Ann Surg. 1999 Jun;229(6):824-31; discussion 831-3. doi: 10.1097/00000658-199906000-00009. Ann Surg. 1999. PMID: 10363896 Free PMC article.
7,914 results